May-Lucie Meyer, Medical Oncologist at Lausanne University Hospital, shared a post on LinkedIn:
Happy to share our latest publication in ESMO Open:
‘Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.’
Title: Antibody–drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation
Authors: S. Peters, M.-L. Meyer, F. André, G. Argilés, A.A. Azizi, S. Banerjee, S. Burgers, G. Curigliano, J.Z. Drago, E. Fontana, E.B. Garon, N. Klümper, L. Le Bescond, F. Lopez-Rios, G. Mountzios, A. Passaro, L. Paz-Ares, B. Pistilli, T. Powles, N. Reguart, J. Remon, T. Schmelzle, M.J. Skynner, E. Smit, E. Smyth, C. Swanton, E. Van Cutsem, S. Loi, R.A. Stahel
Read The Full Article
As ADCs continue to reshape the treatment of solid tumours, this multidisciplinary position statement reviews the latest clinical evidence, discusses emerging biomarkers and novel ADC technologies, and provides expert recommendations to guide future clinical development and implementation.
It was a privilege to contribute to this publication alongside outstanding colleagues, including Peters Solange, fabrice andre, Dr. Alexander A. Azizi, Giuseppe Curigliano, Josh Drago, MD, MS, Enriqueta Felip, Giannis Mountzios, Tom Powles, Charles Swanton, Sherene Loi, Niklas Klümper, MD, Antonio Passaro, Noemi Reguart, MD, PhD, Elizabeth Smyth, Rolf Stahel and many others. Thank you to the ETOPIBCSG Partners Foundation for making this initiative possible.
Other articles about ESMO on OncoDaily.